Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

Explore clinical trials studying Metastatic Castrate-Resistant Prostate Cancer (mCRPC). Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Castrate-Resistant Prostate Cancer (mCRPC) trial results

Recruiting

Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer

NCT07002320

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Oncology Institute of Southern Switzerland Bellinzona, Switzerland
  • Belfast Health and Social Care Trust Belfast, United Kingdom
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Drug Development Unit Sutton, United Kingdom
View Trial Details
Recruiting

TmPSMA-02 in mCRPC

NCT06046040

Conditions
Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Locations
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions